Adult nasolacrimal sac mucocele is an uncommon mass arising in the medial canthal region of the orbit. Twenty-one cases with lacrimal sac mucocele were reviewed retrospectively. We gathered information about the clinical characteristics, natural history, mechanism for mucocele formation and optimal management of this disorder. The results show that the medial canthal mass was confirmed to be dacryocystocele-associated with distal nasolacrimal duct obstruction and proximal obstruction at the junction of the common canaliculus and sac. The interventional procedure of polyurethane stent placement is a practicable and simplified treatment for lacrimal sac mucocele.

1.
Harris GJ, DiClementi D: Congenital dacryocystocele. Arch Ophthalmol 1982;100:1763–1765.
2.
Weinstein GS, Biglan AW, Patterson JH: Congenital lacrimal sac mucocele. Am J Ophthalmol 1982;94:106–110.
3.
Rand PK, Ball WS Jr, Kulwin DR: Congenital nasolacrimal sac mucocele: CT evaluation. Radiology 1989;173:691–694.
4.
Mansour AM, Cheng KP, Mumma JV, et al: Congenital dacryocele: a collaborative review. Ophthalmology 1991;98:1744–1751.
5.
Duke-Elder SS (ed): System of Ophthalmology, vol 3: Normal and Abnormal Development. 2. Congenital Deformities. St Louis, Mosby, 1964, pp 934–941.
6.
Yee SW, Seibert RW, Bower CM, et al: Congenital nasolacrimal duct mucocele: a cause of respiratory distress. Int J Pediatr Otorhinolaryngol 1994;29:151–158.
7.
Edmond JC, Keech RV: Congenital nasolacrimal sac mucocele associated with respiratory distress. J Pediatr Ophthalmol Strabismus 1991;28:287–289.
8.
Chee CY, Cincinnati O, Timothy JM, et al: Adult nasolacrimal duct mucocele. Arch Ophthalmol 2003;121:1605–1606.
9.
Woo KI, Kim Y-D: Four cases of dacryocystocele. Korean J Ophthalmol 1997;11:65–69.
10.
Song HY, Jin YH, Kim JH, et al: Nasolacrimal duct obstruction treated nonsurgically with use of plastic stents. Radiology 1994;190:535–539.
11.
Song HY, Jin YH, Kim JH, et al: Nonsurgical placement of a nasolacrimal polyurethane stent. Radiology 1995;194:233–237.
12.
Song HY, Jin YH, Kim JH, et al: Nonsurgical placement of a nasolacrimal polyurethane stent: long-term effectiveness. Radiology 1996;200:759–776.
13.
Rheeman CH, Meuer DR: Enlargement of the nasolacrimal canal in the absence of neoplasia. Ophthalmology 1998;105:1498–1503.
14.
Stefanyszyn MA, Hidayat AA, Peer JJ, et al: Lacrimal sac tumors. Ophthal Plast Reconstr Surg 1994;10:169–184.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.